相关实验视频

Updated: Jul 12, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

在治疗沃尔登斯特罗姆巨球蛋白血症方面取得了进展

Eric Durot¹, Cécile Tomowiak²

¹Hématologie Clinique, CHU de Reims Et UFR Médecine, Reims, France. edurot@chu-reims.fr.

Current oncology reports

|October 19, 2023

概括

由于遗传学的发现,沃尔登斯特罗姆巨型球蛋白血症 (WM) 的治疗方法得到了进步. 目前的选择,如化学免疫疗法和BTK抑制剂,有很大的差异,正在进行新药试验.

科学领域:

血液学血液学血液学
在瘤学瘤学.
遗传学是一个遗传学.

背景情况:

沃尔登斯特罗姆巨型球蛋白血症 (WM) 是一种罕见的B细胞淋巴增殖性疾病.
最近对体突变的发现 (例如,MYD88,CXCR4) 刺激了治疗方面的进步.

研究的目的:

审查当前和新兴的WM治疗方法.
专注于最近的研究和新型治疗剂.

主要方法:

最近几年发表的研究文献综述.
分析可用的治疗选择及其有效性.

主要成果:

对于以前未接受过治疗的患者的第一线治疗,没有国际共识.
化疗免疫疗法和BTK抑制剂是常见的前线选择,但有很大的不同.
对这些选择进行比较的随机试验有限.

结论:

在WM中,治疗决策应考虑瘤基因型,患者的并发症和治疗后勤.
未来的临床试验正在评估固定的持续时间组合和新药.

关键词:

这是一种BTK抑制剂.化学免疫疗法是一种化学免疫疗法.在MYD88突变中.沃尔登斯特罗姆的巨型球蛋白血症

更多相关视频

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...